

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.54885615 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.54885615 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.54885615 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.54885615 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.54885615 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.54885615 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.41014709 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.28024278 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.01476434 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.97064558 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.96856833 |
| 12 | response to peptidoglycan (GO:0032494) | 4.88195721 |
| 13 | detection of other organism (GO:0098543) | 4.62339898 |
| 14 | detection of bacterium (GO:0016045) | 4.56169677 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 4.54802282 |
| 16 | response to muramyl dipeptide (GO:0032495) | 4.52677034 |
| 17 | neutrophil mediated immunity (GO:0002446) | 4.44455777 |
| 18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.43237875 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.34581454 |
| 20 | response to host immune response (GO:0052572) | 4.34581454 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.29708563 |
| 22 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.16117868 |
| 23 | natural killer cell mediated immunity (GO:0002228) | 4.16117868 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 4.14802806 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 4.06994266 |
| 26 | respiratory burst (GO:0045730) | 3.97111839 |
| 27 | positive regulation of antigen processing and presentation (GO:0002579) | 3.95372214 |
| 28 | response to host (GO:0075136) | 3.94062478 |
| 29 | response to host defenses (GO:0052200) | 3.94062478 |
| 30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.94062478 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.93887797 |
| 32 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.93154240 |
| 33 | microglial cell activation (GO:0001774) | 3.90033227 |
| 34 | myeloid cell activation involved in immune response (GO:0002275) | 3.84053756 |
| 35 | neutrophil activation (GO:0042119) | 3.81937412 |
| 36 | granulocyte activation (GO:0036230) | 3.76009595 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.68190611 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.67095841 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.67095841 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.63442062 |
| 41 | I-kappaB phosphorylation (GO:0007252) | 3.62381018 |
| 42 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.60695077 |
| 43 | pinocytosis (GO:0006907) | 3.54121974 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51748791 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.49196018 |
| 46 | macrophage activation (GO:0042116) | 3.48082482 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.46683320 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.46683320 |
| 49 | detection of biotic stimulus (GO:0009595) | 3.44709341 |
| 50 | positive regulation of interferon-beta production (GO:0032728) | 3.36075696 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34263517 |
| 52 | myeloid leukocyte mediated immunity (GO:0002444) | 3.33279746 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.32432294 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 3.32078859 |
| 55 | defense response to protozoan (GO:0042832) | 3.31246482 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.29599867 |
| 57 | leukocyte mediated cytotoxicity (GO:0001909) | 3.24887655 |
| 58 | germinal center formation (GO:0002467) | 3.23895066 |
| 59 | NIK/NF-kappaB signaling (GO:0038061) | 3.20186122 |
| 60 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.19252102 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 3.19133401 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.17492539 |
| 63 | negative regulation of granulocyte differentiation (GO:0030853) | 3.17095188 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14069686 |
| 65 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12129608 |
| 66 | response to type I interferon (GO:0034340) | 3.10555775 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.09624675 |
| 68 | type I interferon signaling pathway (GO:0060337) | 3.09624675 |
| 69 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.08889690 |
| 70 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.07873429 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 3.07528849 |
| 72 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07511706 |
| 73 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.06215156 |
| 74 | B cell receptor signaling pathway (GO:0050853) | 3.05690735 |
| 75 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02648902 |
| 76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.02643644 |
| 77 | regulation of tolerance induction (GO:0002643) | 3.01375567 |
| 78 | positive thymic T cell selection (GO:0045059) | 2.98859686 |
| 79 | regulation of B cell differentiation (GO:0045577) | 2.98359554 |
| 80 | detection of molecule of bacterial origin (GO:0032490) | 2.97885591 |
| 81 | mannose metabolic process (GO:0006013) | 2.97741349 |
| 82 | response to interleukin-15 (GO:0070672) | 2.96330917 |
| 83 | negative regulation of innate immune response (GO:0045824) | 2.96137468 |
| 84 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94133223 |
| 85 | apoptotic cell clearance (GO:0043277) | 2.93941418 |
| 86 | regulation of mast cell activation (GO:0033003) | 2.93361638 |
| 87 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.92594359 |
| 88 | response to protozoan (GO:0001562) | 2.90089186 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.88453587 |
| 90 | negative regulation of interleukin-17 production (GO:0032700) | 2.87040278 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.85503000 |
| 92 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85442120 |
| 93 | negative regulation of lipid storage (GO:0010888) | 2.85374808 |
| 94 | B cell homeostasis (GO:0001782) | 2.85178869 |
| 95 | T cell migration (GO:0072678) | 2.85072870 |
| 96 | B cell mediated immunity (GO:0019724) | 2.82873904 |
| 97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82247059 |
| 98 | modulation by symbiont of host cellular process (GO:0044068) | 2.81972411 |
| 99 | response to interferon-alpha (GO:0035455) | 2.81926523 |
| 100 | myeloid dendritic cell differentiation (GO:0043011) | 2.81119414 |
| 101 | negative thymic T cell selection (GO:0045060) | 2.80724888 |
| 102 | myeloid leukocyte activation (GO:0002274) | 2.80585003 |
| 103 | leukocyte aggregation (GO:0070486) | 2.80562758 |
| 104 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.79290405 |
| 105 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.77641950 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 2.77208136 |
| 107 | tolerance induction (GO:0002507) | 2.76650944 |
| 108 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.74279818 |
| 109 | positive regulation of heat generation (GO:0031652) | 2.73332838 |
| 110 | regulation of leukocyte degranulation (GO:0043300) | 2.73085765 |
| 111 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.72380633 |
| 112 | response to fungus (GO:0009620) | 2.72190557 |
| 113 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.71621465 |
| 114 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.71621465 |
| 115 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.70343264 |
| 116 | positive regulation of mast cell degranulation (GO:0043306) | 2.70343264 |
| 117 | regulation of regulated secretory pathway (GO:1903305) | 2.69203988 |
| 118 | regulation of integrin activation (GO:0033623) | 2.68126580 |
| 119 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.67070923 |
| 120 | positive regulation of mast cell activation (GO:0033005) | 2.66959838 |
| 121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.66938186 |
| 122 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66694168 |
| 123 | T-helper 1 type immune response (GO:0042088) | 2.66069743 |
| 124 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.65694011 |
| 125 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.64314529 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.63951792 |
| 127 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.63826276 |
| 128 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.63495272 |
| 129 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.63212521 |
| 130 | superoxide anion generation (GO:0042554) | 2.63111642 |
| 131 | cellular extravasation (GO:0045123) | 2.62519154 |
| 132 | regulation of cholesterol storage (GO:0010885) | 2.59950661 |
| 133 | leukocyte degranulation (GO:0043299) | 2.59307174 |
| 134 | regulation of interferon-beta production (GO:0032648) | 2.58916685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.87808347 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.81141019 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.64673268 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.26047819 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.20977412 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.67322920 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.64233910 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60063306 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.20801122 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.20212785 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.18159266 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.91419527 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.85866012 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75303003 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63184949 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54527949 |
| 17 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.47271220 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.43055022 |
| 19 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41922401 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31731761 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.30755808 |
| 22 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.27427961 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.25629320 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23309153 |
| 25 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.19992277 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.19391443 |
| 27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.04901726 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00289345 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95465928 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91752436 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89728255 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.83131060 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81667647 |
| 34 | * MAF_26560356_Chip-Seq_TH1_Human | 1.77344829 |
| 35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.72835963 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70366437 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.67811551 |
| 38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66624625 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65188026 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64186350 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61284388 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.61151781 |
| 43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.58996987 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58320841 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54087487 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51563613 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48977287 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48699117 |
| 49 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45257339 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44173958 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.43597629 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.43327252 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41105377 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37880073 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37048858 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36592997 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35648764 |
| 58 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35499328 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35093652 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34174397 |
| 61 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31349168 |
| 62 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30477151 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29809117 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28585772 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26040542 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25448286 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25244253 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22994573 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20370752 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20271010 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19732005 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19415133 |
| 73 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18274572 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17625905 |
| 75 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16903896 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16353359 |
| 77 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12762733 |
| 78 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11753677 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11338228 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10781837 |
| 81 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10658814 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10583737 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09989937 |
| 84 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09720517 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07019263 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06337138 |
| 87 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06074926 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 1.05626287 |
| 89 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04311844 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04042423 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02669923 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02396321 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01844387 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 1.01360256 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00606308 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99093039 |
| 97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99037794 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97504744 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96846486 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96090462 |
| 101 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96051268 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90845781 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89361797 |
| 104 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89212843 |
| 105 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87617286 |
| 106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87138754 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84854685 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84761514 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84257396 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81313194 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79989241 |
| 112 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79655265 |
| 113 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.78271761 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76292817 |
| 115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76241717 |
| 116 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.75596595 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75239000 |
| 118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75239000 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74824230 |
| 120 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74353495 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73229877 |
| 122 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72850346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.29586034 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.02337393 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.71358024 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.58373061 |
| 5 | MP0003303_peritoneal_inflammation | 3.14615222 |
| 6 | MP0003436_decreased_susceptibility_to | 3.07550833 |
| 7 | * MP0002419_abnormal_innate_immunity | 2.90434749 |
| 8 | MP0005174_abnormal_tail_pigmentation | 2.67523960 |
| 9 | MP0006082_CNS_inflammation | 2.63724443 |
| 10 | MP0009785_altered_susceptibility_to | 2.47975209 |
| 11 | MP0005025_abnormal_response_to | 2.46141293 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.42959147 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.39511421 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.37305005 |
| 15 | MP0009278_abnormal_bone_marrow | 2.36196062 |
| 16 | MP0000685_abnormal_immune_system | 2.33811890 |
| 17 | * MP0001800_abnormal_humoral_immune | 2.27882637 |
| 18 | MP0004510_myositis | 2.22421133 |
| 19 | * MP0005387_immune_system_phenotype | 2.18694363 |
| 20 | * MP0001790_abnormal_immune_system | 2.18694363 |
| 21 | MP0009840_abnormal_foam_cell | 2.17280600 |
| 22 | * MP0002723_abnormal_immune_serum | 2.16667451 |
| 23 | MP0000015_abnormal_ear_pigmentation | 2.08383728 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.08034373 |
| 25 | * MP0001819_abnormal_immune_cell | 1.99403027 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 1.97351446 |
| 27 | MP0005671_abnormal_response_to | 1.92071757 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.92047225 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.88486468 |
| 30 | MP0004947_skin_inflammation | 1.88280419 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.88099101 |
| 32 | MP0005451_abnormal_body_composition | 1.79709458 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.73641199 |
| 34 | MP0002405_respiratory_system_inflammati | 1.71329461 |
| 35 | MP0003724_increased_susceptibility_to | 1.70619470 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.68739982 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.59175900 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.59175900 |
| 39 | MP0010307_abnormal_tumor_latency | 1.57800933 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.53987339 |
| 41 | MP0000371_diluted_coat_color | 1.50740111 |
| 42 | MP0003448_altered_tumor_morphology | 1.50576258 |
| 43 | * MP0000716_abnormal_immune_system | 1.49520015 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.48571123 |
| 45 | MP0001853_heart_inflammation | 1.48545927 |
| 46 | MP0008469_abnormal_protein_level | 1.46797199 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.46175102 |
| 48 | * MP0002398_abnormal_bone_marrow | 1.45565725 |
| 49 | MP0002006_tumorigenesis | 1.43598444 |
| 50 | * MP0000689_abnormal_spleen_morphology | 1.43564102 |
| 51 | MP0000604_amyloidosis | 1.37131230 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.33641922 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.32958221 |
| 54 | MP0008260_abnormal_autophagy | 1.32580948 |
| 55 | MP0001873_stomach_inflammation | 1.32051827 |
| 56 | MP0000858_altered_metastatic_potential | 1.30724096 |
| 57 | MP0003866_abnormal_defecation | 1.28981813 |
| 58 | MP0003690_abnormal_glial_cell | 1.26054259 |
| 59 | MP0001958_emphysema | 1.25895141 |
| 60 | * MP0002722_abnormal_immune_system | 1.23688821 |
| 61 | * MP0002429_abnormal_blood_cell | 1.23254866 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.22287517 |
| 63 | MP0000343_altered_response_to | 1.17783899 |
| 64 | MP0004883_abnormal_blood_vessel | 1.17338445 |
| 65 | MP0002132_abnormal_respiratory_system | 1.17320635 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.16873720 |
| 67 | MP0009764_decreased_sensitivity_to | 1.13405485 |
| 68 | MP0003075_altered_response_to | 1.13046951 |
| 69 | MP0001851_eye_inflammation | 1.12539502 |
| 70 | * MP0002998_abnormal_bone_remodeling | 1.11625560 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.11073897 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.09655392 |
| 73 | MP0002933_joint_inflammation | 1.08994475 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 1.08120683 |
| 75 | MP0005164_abnormal_response_to | 1.04573791 |
| 76 | MP0008004_abnormal_stomach_pH | 1.02605718 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.99033882 |
| 78 | MP0009763_increased_sensitivity_to | 0.95859512 |
| 79 | MP0005083_abnormal_biliary_tract | 0.95305317 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.95298803 |
| 81 | MP0005310_abnormal_salivary_gland | 0.94295946 |
| 82 | MP0001663_abnormal_digestive_system | 0.91239881 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 0.90307455 |
| 84 | MP0003091_abnormal_cell_migration | 0.88143797 |
| 85 | MP0003279_aneurysm | 0.86629667 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.86211858 |
| 87 | MP0000490_abnormal_crypts_of | 0.85441595 |
| 88 | MP0005166_decreased_susceptibility_to | 0.84815371 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.82575182 |
| 90 | MP0005023_abnormal_wound_healing | 0.81050613 |
| 91 | MP0004381_abnormal_hair_follicle | 0.80282396 |
| 92 | MP0005390_skeleton_phenotype | 0.79233066 |
| 93 | MP0001849_ear_inflammation | 0.77339487 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.74570953 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.73897511 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.72559813 |
| 97 | MP0002139_abnormal_hepatobiliary_system | 0.72011218 |
| 98 | MP0003828_pulmonary_edema | 0.72010525 |
| 99 | MP0003763_abnormal_thymus_physiology | 0.71825368 |
| 100 | * MP0000703_abnormal_thymus_morphology | 0.71739824 |
| 101 | MP0000249_abnormal_blood_vessel | 0.71451228 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.70208495 |
| 103 | MP0003045_fibrosis | 0.68145484 |
| 104 | MP0003705_abnormal_hypodermis_morpholog | 0.67472248 |
| 105 | MP0008874_decreased_physiological_sensi | 0.66966937 |
| 106 | MP0003329_amyloid_beta_deposits | 0.66487925 |
| 107 | MP0002254_reproductive_system_inflammat | 0.65674515 |
| 108 | MP0000609_abnormal_liver_physiology | 0.63283087 |
| 109 | MP0005197_abnormal_uvea_morphology | 0.62888491 |
| 110 | MP0002075_abnormal_coat/hair_pigmentati | 0.62378121 |
| 111 | MP0001915_intracranial_hemorrhage | 0.60977775 |
| 112 | MP0004858_abnormal_nervous_system | 0.60544218 |
| 113 | * MP0003795_abnormal_bone_structure | 0.59103956 |
| 114 | MP0005621_abnormal_cell_physiology | 0.58711024 |
| 115 | MP0001243_abnormal_dermal_layer | 0.58613133 |
| 116 | MP0002928_abnormal_bile_duct | 0.58175116 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.58167067 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.57673772 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.57576734 |
| 120 | MP0000920_abnormal_myelination | 0.56556431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.79884290 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.35038596 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.47230798 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.90080501 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.77752521 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.66929762 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.52601239 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.16528219 |
| 9 | Recurrent skin infections (HP:0001581) | 4.01381907 |
| 10 | Gingivitis (HP:0000230) | 3.92108171 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.91049742 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.90673859 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.90673859 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.90673859 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.83254449 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.75763094 |
| 17 | Periodontitis (HP:0000704) | 3.75725016 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.64926925 |
| 19 | Myositis (HP:0100614) | 3.60549791 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.56172150 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.40380894 |
| 22 | Axonal loss (HP:0003447) | 3.37694484 |
| 23 | Stomatitis (HP:0010280) | 3.29776781 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.28653501 |
| 25 | Recurrent viral infections (HP:0004429) | 3.21689555 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.14255804 |
| 27 | Orchitis (HP:0100796) | 3.08933622 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.08296928 |
| 29 | Obstructive lung disease (HP:0006536) | 3.08296928 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01404266 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01404266 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01404266 |
| 33 | Disinhibition (HP:0000734) | 2.90647267 |
| 34 | Cellulitis (HP:0100658) | 2.90137050 |
| 35 | Encephalitis (HP:0002383) | 2.89390473 |
| 36 | Glomerulonephritis (HP:0000099) | 2.87411472 |
| 37 | Pustule (HP:0200039) | 2.85880552 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.85676011 |
| 39 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85676011 |
| 40 | Vasculitis (HP:0002633) | 2.82880797 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 2.82855563 |
| 42 | Optic neuritis (HP:0100653) | 2.82855563 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.81708924 |
| 44 | Prostate neoplasm (HP:0100787) | 2.80816041 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80529499 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80529499 |
| 47 | Gingival bleeding (HP:0000225) | 2.74651273 |
| 48 | Loss of speech (HP:0002371) | 2.73610202 |
| 49 | Thick nail (HP:0001805) | 2.70952353 |
| 50 | Myocardial infarction (HP:0001658) | 2.64527401 |
| 51 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.60309388 |
| 52 | Colitis (HP:0002583) | 2.59699501 |
| 53 | Petechiae (HP:0000967) | 2.58257406 |
| 54 | Purpura (HP:0000979) | 2.58050748 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.57434845 |
| 56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56926475 |
| 57 | Thoracic kyphosis (HP:0002942) | 2.54141071 |
| 58 | Chest pain (HP:0100749) | 2.52949811 |
| 59 | Malnutrition (HP:0004395) | 2.50646271 |
| 60 | Hematochezia (HP:0002573) | 2.49745617 |
| 61 | Meningitis (HP:0001287) | 2.45503151 |
| 62 | Basal ganglia calcification (HP:0002135) | 2.44532047 |
| 63 | Increased serum ferritin (HP:0003281) | 2.43437841 |
| 64 | Gastrointestinal stroma tumor (HP:0100723) | 2.43163797 |
| 65 | Chronic otitis media (HP:0000389) | 2.43044614 |
| 66 | T lymphocytopenia (HP:0005403) | 2.38370580 |
| 67 | Leukocytosis (HP:0001974) | 2.38143954 |
| 68 | Hepatosplenomegaly (HP:0001433) | 2.37878607 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.35623093 |
| 70 | Joint hemorrhage (HP:0005261) | 2.31858556 |
| 71 | Panhypogammaglobulinemia (HP:0003139) | 2.29565301 |
| 72 | Epistaxis (HP:0000421) | 2.28592351 |
| 73 | * Osteomyelitis (HP:0002754) | 2.26340276 |
| 74 | Abnormality of the thoracic spine (HP:0100711) | 2.26038642 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24876755 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.24876755 |
| 77 | Urticaria (HP:0001025) | 2.23456543 |
| 78 | Abnormality of T cell number (HP:0011839) | 2.22504756 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.22402169 |
| 80 | Impaired platelet aggregation (HP:0003540) | 2.22296794 |
| 81 | Abnormal platelet function (HP:0011869) | 2.22296794 |
| 82 | Amyloidosis (HP:0011034) | 2.22044524 |
| 83 | Pulmonary embolism (HP:0002204) | 2.21272931 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 2.20017381 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.19250218 |
| 86 | Recurrent pneumonia (HP:0006532) | 2.18986376 |
| 87 | Albinism (HP:0001022) | 2.18139350 |
| 88 | Episodic fever (HP:0001954) | 2.16773751 |
| 89 | Increased IgM level (HP:0003496) | 2.16755930 |
| 90 | Agnosia (HP:0010524) | 2.15799005 |
| 91 | Prolonged bleeding time (HP:0003010) | 2.15437986 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.13934586 |
| 93 | Lymphopenia (HP:0001888) | 2.13740524 |
| 94 | Arterial thrombosis (HP:0004420) | 2.13360368 |
| 95 | Upper motor neuron abnormality (HP:0002127) | 2.10831553 |
| 96 | Anorexia (HP:0002039) | 2.08649898 |
| 97 | Absent frontal sinuses (HP:0002688) | 2.08498609 |
| 98 | Nephritis (HP:0000123) | 2.08375378 |
| 99 | Eosinophilia (HP:0001880) | 2.06830965 |
| 100 | Peritonitis (HP:0002586) | 2.06575527 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.06527367 |
| 102 | J-shaped sella turcica (HP:0002680) | 2.05967762 |
| 103 | Abnormality of the nasal mucosa (HP:0000433) | 2.05573590 |
| 104 | Abnormality of the fingertips (HP:0001211) | 2.05304444 |
| 105 | Abnormality of T cells (HP:0002843) | 2.05227243 |
| 106 | Hypochromic anemia (HP:0001931) | 2.05077948 |
| 107 | Emphysema (HP:0002097) | 2.04501644 |
| 108 | Agammaglobulinemia (HP:0004432) | 2.01299434 |
| 109 | Hemoptysis (HP:0002105) | 2.00248213 |
| 110 | Restrictive lung disease (HP:0002091) | 1.99980111 |
| 111 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98975609 |
| 112 | Sepsis (HP:0100806) | 1.98499227 |
| 113 | Abnormality of the pleura (HP:0002103) | 1.98072900 |
| 114 | Spontaneous hematomas (HP:0007420) | 1.94911331 |
| 115 | Glomerulopathy (HP:0100820) | 1.92701744 |
| 116 | Abnormality of the prostate (HP:0008775) | 1.88638604 |
| 117 | Peripheral demyelination (HP:0011096) | 1.86903728 |
| 118 | Cerebral aneurysm (HP:0004944) | 1.86495865 |
| 119 | Abnormality of the peritoneum (HP:0002585) | 1.85841341 |
| 120 | Frequent falls (HP:0002359) | 1.85207676 |
| 121 | Urethral obstruction (HP:0000796) | 1.84170730 |
| 122 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83030994 |
| 123 | Acne (HP:0001061) | 1.82811549 |
| 124 | Nasal polyposis (HP:0100582) | 1.82732192 |
| 125 | Cheilitis (HP:0100825) | 1.82357739 |
| 126 | Slow saccadic eye movements (HP:0000514) | 1.81286526 |
| 127 | * Bone pain (HP:0002653) | 1.80917116 |
| 128 | Deformed sella turcica (HP:0002681) | 1.79842995 |
| 129 | IgM deficiency (HP:0002850) | 1.78214002 |
| 130 | Skin ulcer (HP:0200042) | 1.77922437 |
| 131 | Leukopenia (HP:0001882) | 1.77112464 |
| 132 | Granulocytopenia (HP:0001913) | 1.76984246 |
| 133 | Increased IgE level (HP:0003212) | 1.76164030 |
| 134 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76089102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.47419774 |
| 2 | RIPK4 | 3.41745587 |
| 3 | IRAK3 | 3.37875796 |
| 4 | TYK2 | 3.28928136 |
| 5 | MAP3K14 | 3.26719687 |
| 6 | IRAK4 | 3.20739205 |
| 7 | MAP4K1 | 3.00121893 |
| 8 | TBK1 | 2.96028019 |
| 9 | PRPF4B | 2.73514391 |
| 10 | BLK | 2.64755578 |
| 11 | IKBKE | 2.48102264 |
| 12 | TAOK3 | 2.43373684 |
| 13 | ERN1 | 2.40567088 |
| 14 | TNK2 | 2.04661439 |
| 15 | CSF1R | 2.01911509 |
| 16 | JAK3 | 2.01065198 |
| 17 | MAP3K13 | 1.96954568 |
| 18 | JAK1 | 1.96279096 |
| 19 | SIK2 | 1.95091423 |
| 20 | IKBKB | 1.92655909 |
| 21 | TGFBR2 | 1.87666313 |
| 22 | CAMK1D | 1.81664657 |
| 23 | TTN | 1.78900629 |
| 24 | FES | 1.78117495 |
| 25 | MAP3K11 | 1.74504744 |
| 26 | HCK | 1.68359592 |
| 27 | TAOK1 | 1.66767666 |
| 28 | ZAP70 | 1.60292886 |
| 29 | CAMK1G | 1.57183714 |
| 30 | EPHB1 | 1.54513049 |
| 31 | SYK | 1.43696804 |
| 32 | BTK | 1.41489527 |
| 33 | CSK | 1.38605387 |
| 34 | SIK3 | 1.36933344 |
| 35 | TXK | 1.33757222 |
| 36 | PTK6 | 1.26552377 |
| 37 | TAOK2 | 1.25930255 |
| 38 | MAP2K3 | 1.24345561 |
| 39 | CDC42BPA | 1.24313946 |
| 40 | CDK12 | 1.23040571 |
| 41 | LCK | 1.20186394 |
| 42 | CHUK | 1.19319304 |
| 43 | MAP3K1 | 1.18473215 |
| 44 | TRPM7 | 1.13771797 |
| 45 | SMG1 | 1.09860942 |
| 46 | CLK1 | 1.08578778 |
| 47 | MAP3K10 | 1.08495430 |
| 48 | LYN | 1.08041348 |
| 49 | PRKD2 | 1.07880311 |
| 50 | NEK9 | 1.07087151 |
| 51 | TEC | 1.04231563 |
| 52 | MARK2 | 1.04231437 |
| 53 | RPS6KA4 | 1.03618942 |
| 54 | STK10 | 1.03527437 |
| 55 | TESK2 | 1.02375280 |
| 56 | FGR | 1.00172304 |
| 57 | NME2 | 0.97869375 |
| 58 | CDK6 | 0.95401816 |
| 59 | JAK2 | 0.94563083 |
| 60 | STK4 | 0.93740289 |
| 61 | TRIB3 | 0.91384798 |
| 62 | MAP3K6 | 0.88427927 |
| 63 | PIM1 | 0.86407232 |
| 64 | RIPK1 | 0.85371018 |
| 65 | KSR2 | 0.83302659 |
| 66 | MARK3 | 0.81285987 |
| 67 | FGFR4 | 0.77696091 |
| 68 | PKN2 | 0.77647921 |
| 69 | PIM2 | 0.76322373 |
| 70 | NEK2 | 0.75260069 |
| 71 | MATK | 0.72188260 |
| 72 | PAK4 | 0.71880413 |
| 73 | ITK | 0.69985912 |
| 74 | MAP3K7 | 0.68750010 |
| 75 | ABL1 | 0.68454392 |
| 76 | GRK7 | 0.68225166 |
| 77 | IRAK1 | 0.67855172 |
| 78 | IRAK2 | 0.67698515 |
| 79 | BRD4 | 0.67483801 |
| 80 | EGFR | 0.66986388 |
| 81 | HIPK2 | 0.65961695 |
| 82 | DAPK2 | 0.65083330 |
| 83 | YES1 | 0.60425434 |
| 84 | RPS6KA6 | 0.59292892 |
| 85 | EIF2AK2 | 0.56467641 |
| 86 | PBK | 0.56117200 |
| 87 | BMPR2 | 0.55742300 |
| 88 | DDR2 | 0.55164551 |
| 89 | MAP2K6 | 0.55158124 |
| 90 | BMX | 0.53064455 |
| 91 | PRKG2 | 0.50396812 |
| 92 | SIK1 | 0.50354533 |
| 93 | MAP3K3 | 0.48265006 |
| 94 | RPS6KL1 | 0.47263836 |
| 95 | RPS6KC1 | 0.47263836 |
| 96 | GRK6 | 0.46806201 |
| 97 | ICK | 0.46705390 |
| 98 | RPS6KA2 | 0.45792944 |
| 99 | MOS | 0.44077922 |
| 100 | CAMKK2 | 0.43726075 |
| 101 | DYRK1B | 0.41871879 |
| 102 | MAP2K2 | 0.41295355 |
| 103 | PDGFRB | 0.41003976 |
| 104 | FLT3 | 0.40678955 |
| 105 | PRKCD | 0.38885257 |
| 106 | PDPK1 | 0.38480108 |
| 107 | MAPK12 | 0.38215213 |
| 108 | PRKCQ | 0.37801794 |
| 109 | STK3 | 0.37056023 |
| 110 | FYN | 0.36701330 |
| 111 | CDK4 | 0.35947185 |
| 112 | CAMKK1 | 0.35682751 |
| 113 | MAP3K8 | 0.35170330 |
| 114 | FGFR3 | 0.35103050 |
| 115 | PTK2B | 0.34833842 |
| 116 | SCYL2 | 0.34548572 |
| 117 | LRRK2 | 0.34076319 |
| 118 | PDK1 | 0.34027281 |
| 119 | MTOR | 0.33559874 |
| 120 | RET | 0.33107380 |
| 121 | MAPKAPK2 | 0.32417801 |
| 122 | DAPK3 | 0.32291036 |
| 123 | PIK3CG | 0.32109271 |
| 124 | SGK3 | 0.32008739 |
| 125 | MAPK7 | 0.31987661 |
| 126 | EPHA3 | 0.31929550 |
| 127 | MAP3K5 | 0.31766783 |
| 128 | SRC | 0.28712499 |
| 129 | ATR | 0.27877571 |
| 130 | MAPK11 | 0.27819800 |
| 131 | ABL2 | 0.26587081 |
| 132 | PKN1 | 0.26060982 |
| 133 | MAPK4 | 0.24126063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04842699 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.96981863 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.84793667 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.69665276 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.54544262 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.54242651 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49142662 |
| 8 | * Lysosome_Homo sapiens_hsa04142 | 2.44388974 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.36867560 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21363084 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16591273 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.12369320 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.12051690 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.11542504 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.08566130 |
| 16 | Measles_Homo sapiens_hsa05162 | 2.05652376 |
| 17 | * Tuberculosis_Homo sapiens_hsa05152 | 2.00111757 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97556250 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.82236065 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.82023158 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80247072 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.72248419 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58587360 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56628681 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53480908 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.51802319 |
| 27 | * Phagosome_Homo sapiens_hsa04145 | 1.48768517 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46182128 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44765603 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42661771 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41408142 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36896689 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32687651 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.28502523 |
| 35 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27827768 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.27452590 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25644657 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.25612184 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25293165 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21159945 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.20650019 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18404347 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.16852729 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16807874 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16705399 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.12701713 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10959401 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08153597 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06391093 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.01932254 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91682638 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91177681 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90976618 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90598144 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90142567 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87935850 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86358432 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.80744543 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78812589 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.77693430 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.75628416 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75139919 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73207279 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72875360 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.67952186 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66402945 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65456961 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.65152391 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63635980 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62232282 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61799386 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61677853 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61378557 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61328394 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60023589 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58608687 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.52970496 |
| 78 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52781121 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52494899 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51687564 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51066590 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50825333 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.50744098 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50487048 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47706357 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47228737 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46235261 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46135239 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45757937 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45748114 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43184048 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41610854 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41473445 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40987551 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.39775884 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39655962 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39540854 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38161229 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36974762 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36920465 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36440986 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36017140 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36011216 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34485847 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32920397 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30573507 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26841166 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26337719 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.25332939 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24196775 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.22867391 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21666386 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.21559485 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21054953 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20870873 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.20097898 |

